Shares of Spire Healthcare Group plc (LON:SPI – Get Free Report) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 214.30 and traded as high as GBX 219.50. Spire Healthcare Group shares last traded at GBX 218, with a volume of 304,620 shares changing hands.
Wall Street Analyst Weigh In
Separately, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 245 price objective on shares of Spire Healthcare Group in a research note on Friday, May 15th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of GBX 276.
Read Our Latest Research Report on SPI
Spire Healthcare Group Price Performance
Spire Healthcare Group Company Profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
Featured Stories
- Five stocks we like better than Spire Healthcare Group
- Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises
- 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks
- Why Wall Street Suddenly Sees SpaceX as an AI Company
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.
